行业动态 本周（12.08-12.14）均价跟踪的100个化工品种中，共有42个品种价格上涨，37个品种价格下跌，21个 品种价格稳定。跟踪的产品中47%的产品月均价环比上涨，44%的产品月均价环比下跌，9%的产品月均 价环比持平。周均价涨幅居前的品种分别是硝酸（华东地区）硫酸（浙江巨化98%）、原盐（山东海 盐）、双酚A（华东）、TDI（华东）；周均价跌幅居前的品种分别是PVA、LLDPE（余姚7042/吉 化）、三氯乙烯（华东）、NYMEX天然气乙二醇。 中银证券近日发布化工行业周报：本周（12.08-12.14）均价跟踪的100个化工品种中，共有42个品种价 格上涨，37个品种价格下跌，21个品种价格稳定。跟踪的产品中47%的产品月均价环比上涨，44%的产 品月均价环比下跌，9%的产品月均价环比持平。 本周（12.08-12.14）国际油价下跌，WTI原油期货价格收于57.44美元/桶，收盘价周跌幅2.45%；布伦特 原油期货价格收于61.12美元/桶，收盘价周跌幅2.19%。宏观方面，美联储宣布将联邦基金利率目标区 间下调25个基点到3.5%至3.75%之间，这是今年以来美联储连续第三次降息。供应方面 ...

证券日报网讯 12月12日，瑞联新材在互动平台回答投资者提问时表示，截至2025年12月10日，公司股 东人数为9878户。 （文章来源：证券日报） ...

证券日报网讯12月10日，瑞联新材在互动平台回答投资者提问时表示，截至2025年11月28日，公司股东 人数为9453户。 ...

（记者 王晓波） 瑞联新材（688550.SH）12月10日在投资者互动平台表示，目前公司新能源项目尚未投产，产线投产进 度主要受市场需求研判等因素综合影响。 每经AI快讯，有投资者在投资者互动平台提问：请问公司的VC产线已经投产了吗？如果还没有投产， 是什么原因？ ...

Core Insights - A total of 21 buy ratings were issued by institutions today, covering 20 stocks, with Guizhou Moutai receiving the highest attention with two buy ratings [1][2] - Among the rated stocks, 11 provided future target prices, with 7 stocks showing an upside potential exceeding 20%, led by Guizhou Moutai with a target price of 2600.00 CNY, indicating a potential increase of 79.56% [1][2] - The average increase for stocks with buy ratings today was 0.82%, outperforming the Shanghai Composite Index, with notable gainers including Hu Guang Co., Sophia, and Shenzhou Digital [1][2] Company Summaries - Guizhou Moutai received a strong buy rating from Huachuang Securities with a target price of 2600.00 CNY, compared to the latest closing price of 1448.00 CNY [2] - Dongpeng Beverage also received a strong buy rating from Huachuang Securities with a target price of 340.00 CNY, latest closing at 269.03 CNY [2] - Shenzhou Digital was rated as "Increase" by Guotai Junan with a target price of 55.97 CNY, latest closing at 41.27 CNY [2] - Hu Guang Co. was rated as "Strong Buy" by Huachuang Securities with a target price of 37.90 CNY, latest closing at 31.30 CNY [2] - Other notable stocks include Jerry Shares, which was rated "Increase" with a target price of 73.20 CNY, latest closing at 62.07 CNY [2] Industry Insights - The basic chemical industry was the most favored, with stocks like Huhua Co. and Chuanheng Co. receiving buy ratings [2] - The computer and automotive industries also attracted attention, with two stocks each receiving buy ratings [2]

Investment Rating - The report maintains a "Buy" rating for the company [4][6]. Core Insights - The company is positioned as a platform enterprise focusing on organic small molecule synthesis, leveraging its core technology in display materials to diversify into pharmaceutical CDMO and electronic materials [1][16]. - The company has established stable partnerships with global pharmaceutical giants and is expanding its pharmaceutical pipeline, with a significant increase in the number of drug candidates [3][21]. - The electronic materials segment is witnessing growth, particularly in semiconductor photoresist materials, with successful validation and ramp-up of production [4][22]. Summary by Sections Display Materials - The display materials sector is experiencing robust growth, with liquid crystal materials benefiting from the increasing size of LCD panels and OLED materials poised for significant expansion due to rising penetration rates in mid-size panels [2][41]. - The company has achieved international leading levels in liquid crystal monomers and is one of the few domestic firms capable of large-scale OLED material production, establishing partnerships with key global players [2][20]. Pharmaceutical CDMO - The company has successfully expanded its pharmaceutical CDMO business, focusing on intermediates and establishing stable collaborations with renowned pharmaceutical companies [3][21]. - As of June 2025, the company has a pipeline of 300 pharmaceutical candidates, reflecting a net increase of 29 candidates compared to the end of 2024 [3][21]. Electronic Materials - The semiconductor photoresist materials are progressing well in validation, with products entering mass production, contributing to revenue growth [4][22]. - The company is also seeing a ramp-up in PI materials, which are expected to enter a growth phase, potentially becoming a significant growth driver for the company [4][22]. Financial Forecast - The company is projected to achieve net profits of 322 million, 384 million, and 500 million yuan for the years 2025, 2026, and 2027, respectively, with corresponding PE ratios of 24.74X, 20.76X, and 15.95X [4][5].

Core Insights - On November 25, 2025, Ruian New Materials (688550) recorded a financing buy of 30.57 million yuan and a financing repayment of 29.34 million yuan, resulting in a net financing buy of 1.23 million yuan. The financing balance stood at 527 million yuan, with a cumulative net buy of 38.55 million yuan over the last three trading days and 12 out of the last 20 trading days showing net financing buys [1][2][3]. Financing Activity Summary - On November 25, 2025, the net financing buy was 1.23 million yuan, with a financing balance of 527 million yuan, representing 6.62% of the circulating market value [2]. - The financing balance increased by 0.23% from the previous day, indicating a slight positive sentiment among investors [3]. - Over the past trading days, significant fluctuations were observed, with the highest net financing buy recorded on November 21 at 29.45 million yuan and a negative net buy on November 19 at -7.47 million yuan [2][3].

Core Insights - The total margin balance of the STAR Market on November 21 reached 251.77 billion yuan, a decrease of 4.746 billion yuan from the previous trading day [1] - The financing balance amounted to 250.91 billion yuan, down by 4.711 billion yuan, while the securities lending balance was 0.865 billion yuan, a reduction of 0.035 billion yuan [1] Individual Stock Performance - On November 21, 217 stocks in the STAR Market experienced net financing inflows, with 8 stocks having net inflow amounts exceeding 20 million yuan [1] - Dekoli topped the list with a net financing inflow of 1.56 billion yuan, followed by Aikesaibo, Yuanjie Technology, Haibosi Chuang, Yangguang Nuohuo, and Ruilian New Materials [1]

Company Overview - Xi'an Ruile New Materials Co., Ltd. is located in Xi'an High-tech Zone, Shaanxi Province, and was established on April 15, 1999. The company was listed on September 2, 2020. Its main business involves the research, development, production, and sales of specialized organic new materials [1]. - The company's revenue composition includes display materials (77.97%), pharmaceutical intermediates (18.63%), and others (3.41%) [1]. Financial Performance - For the period from January to September 2025, the company achieved operating revenue of 1.301 billion yuan, representing a year-on-year growth of 19.01%. The net profit attributable to the parent company was 281 million yuan, showing a year-on-year increase of 51.54% [2]. - Since its A-share listing, the company has distributed a total of 498 million yuan in dividends, with 300 million yuan distributed over the past three years [3]. Stock Performance - As of November 18, the company's stock price was 46.98 yuan per share, with a market capitalization of 8.155 billion yuan. The stock has increased by 53.03% year-to-date, but has seen a decline of 1.72% over the last five trading days and 1.32% over the last twenty days [1]. - The stock's trading volume on November 18 was 44.8366 million yuan, with a turnover rate of 0.55%. The net outflow of main funds was 8.522 million yuan [1]. Shareholder Information - As of November 10, the number of shareholders was 10,000, a decrease of 5.73% from the previous period. The average circulating shares per person increased by 6.08% to 17,278 shares [2].

Meeting Overview - The fourth extraordinary general meeting of shareholders was held on November 17, 2025, in Xi'an, Shaanxi Province [4][5] - The meeting was convened by the board of directors and chaired by Chairman Liu Xiaochun, utilizing a combination of on-site and online voting methods [2][4] Attendance - All 9 current directors attended the meeting, along with the board secretary Wang Yinbin and several senior management personnel [3] Resolutions Passed - The following resolutions were approved: 1. Appointment of the auditing firm for the fiscal year 2025 [4] 2. Purchase of liability insurance for the company and its directors and senior management [4] - All resolutions were passed with more than half of the valid voting rights held by attending shareholders [5] Legal Compliance - The meeting was witnessed by Beijing Junzejun (Shanghai) Law Firm, confirming that the convening, attendance, and voting procedures complied with the Company Law and the company's articles of association [5]